Cargando…
Identification and validation of immune-related biomarkers and potential regulators and therapeutic targets for diabetic kidney disease
BACKGROUND: Diabetic kidney disease (DKD) is a major complication of diabetes and the leading cause of end-stage renal disease worldwide. Renal inflammation and infiltration of immune cells contribute to the development and progression of DKD. Thus, the aim of the present study was to identify and v...
Autores principales: | Chen, Shengnan, Li, Bo, Chen, Lei, Jiang, Hongli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150481/ https://www.ncbi.nlm.nih.gov/pubmed/37127580 http://dx.doi.org/10.1186/s12920-023-01519-6 |
Ejemplares similares
-
Uncovering the mechanism of resveratrol in the treatment of diabetic kidney disease based on network pharmacology, molecular docking, and experimental validation
por: Chen, Shengnan, et al.
Publicado: (2023) -
Integrated Bioinformatics and Clinical Correlation Analysis of Key Genes, Pathways, and Potential Therapeutic Agents Related to Diabetic Nephropathy
por: Chen, Shengnan, et al.
Publicado: (2022) -
Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study
por: Chen, Shengnan, et al.
Publicado: (2022) -
Identification and Validation of Potential Biomarkers and Their Functions in Acute Kidney Injury
por: Chen, Jianwen, et al.
Publicado: (2020) -
Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer
por: Fang, Xuefen, et al.
Publicado: (2022)